MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$12,992,514
EPS
-$3.12
Unit: Dollar
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2026-06-30
2025-06-30
Sales
-
4,942,633
Cost of sales
-
3,236,047
Gross profit
-
1,706,586
Research and development
3,028,473
2,853,920
General and administrative
6,661,372
6,557,822
Amortization and depreciation
205,271
212,839
Loss on disposal of equipment
-7,136
-
Impairment of fixed assets
189,225
-
Impairment of intangible assets
1,457,926
-
Foreign exchange loss
-58,009
-28,471
Total operating expenses
11,607,412
9,653,052
Interest and other income
244,971
155,882
Finance expense
10,700
371,549
Loss from continuing operations before taxes
-11,373,141
-8,162,133
Net loss from continuing operations
-11,373,141
-
Income (loss) from discontinued operations
-1,187,709
-
Income (loss) from discontinued operations
-1,187,709
-
Net loss
-12,560,850
-8,162,133
Deemed dividends
431,664
-
Net loss attributable to common shareholders
-12,992,514
-
Basic EPS
-3.12
-8.36
Diluted EPS
-3.12
-8.36
Basic Average Shares
4,163,598
975,985
Diluted Average Shares
4,163,598
975,985
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
INM Income Statement Sankey Diagram
Sankey diagram visualizing INM income statement for the period
Net loss
attributable to common...
-$12,992,514
Net loss
-$12,560,850
(-53.89%↓ Y/Y)
Deemed dividends
$431,664
Net loss from
continuing operations
-$11,373,141
Income (loss) from
discontinued operations
-$1,187,709
Loss from continuing
operations before taxes
-$11,373,141
(-39.34%↓ Y/Y)
Income (loss) from
discontinued operations
-$1,187,709
Interest and other income
$244,971
(57.15%↑ Y/Y)
Total operating
expenses
$11,607,412
(20.25%↑ Y/Y)
Finance expense
$10,700
(-97.12%↓ Y/Y)
General and
administrative
$6,661,372
(1.58%↑ Y/Y)
Research and development
$3,028,473
(6.12%↑ Y/Y)
Impairment of intangible
assets
$1,457,926
Amortization and
depreciation
$205,271
(-3.56%↓ Y/Y)
Impairment of fixed assets
$189,225
Foreign exchange loss
-$58,009
(-103.75%↓ Y/Y)
Loss on disposal of
equipment
-$7,136
Buy us a coffee
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)